Search - tctmd.com

Displaying 21 - 40 of 120

Sort: Relevancy | Date

News Daily News

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

Michael O'Riordan

June 14, 2023

News Daily News

CABG and PCI Comparable in ACS Patients With Left Main CAD

Michael O'Riordan

June 06, 2023

News Conference News EuroPCR 2023

‘Fascinating’ Unlocking Coronary Stent Prompts Cautious Praise

Michael O'Riordan

May 18, 2023

News Daily News

Enough PCI ‘Versus’ CABG—Time to Focus on Understudied Groups

Michael O'Riordan

May 09, 2023

News Conference News ACC 2023

Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA

Yael L. Maxwell

March 09, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2023

Shelley Wood

March 01, 2023

News Daily News

UK’s NICE Recommends Lower-Risk Thresholds for Statin Therapy

Michael O'Riordan

January 20, 2023

News Daily News

CT Angiography Is Increasing in England, but Downstream Tests Are Not

Michael O'Riordan

January 12, 2023

News Conference News TCT 2022

SCAAR Registry Delves Into Left Main Revascularization Outcomes

Michael O'Riordan

September 19, 2022

News Daily News

CABG Bests PCI in Patients With Good Physical, Mental Health: SYNTAXES

Michael O'Riordan

July 22, 2022

News Daily News

Higher Single-Sample hs-cTnT Threshold Can Safely Exclude MI

Michael O'Riordan

May 13, 2022

News Daily News

Good News and Bad for High-Intensity Statin Use in ASCVD

Michael O'Riordan

May 05, 2022

News Daily News

PCI and CABG Are Complementary Options for Left Main CAD, Say Experts

Michael O'Riordan

April 27, 2022

News Conference News ACC 2022

No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3

Michael O'Riordan

April 13, 2022

News Daily News

DISCHARGE Hailed as a Big Step Forward for CTA in Stable Chest Pain

Michael O'Riordan

March 04, 2022

News Features

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Michael O'Riordan

January 17, 2022

News Daily News

British Medical Groups Express Concern About Inclisiran Rollout

Michael O'Riordan

December 14, 2021

News Conference News AHA 2021

Bentracimab Rapidly, Safely Reverses Ticagrelor in Early REVERSE-IT Data

Yael L. Maxwell

November 15, 2021

News Conference News AHA 2021

No Mortality Difference Between PCI and CABG for Left Main CAD: Meta-analysis

Michael O'Riordan

November 15, 2021

News Conference News TCT 2021

Debating ISCHEMIA: Do the Results Apply to CABG, Too?

Michael O'Riordan

November 10, 2021

Advertisement

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

CABG and PCI Comparable in ACS Patients With Left Main CAD

‘Fascinating’ Unlocking Coronary Stent Prompts Cautious Praise

Enough PCI ‘Versus’ CABG—Time to Focus on Understudied Groups

Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA

TCTMD’s Top 10 Most Popular Stories for February 2023

UK’s NICE Recommends Lower-Risk Thresholds for Statin Therapy

CT Angiography Is Increasing in England, but Downstream Tests Are Not

SCAAR Registry Delves Into Left Main Revascularization Outcomes

CABG Bests PCI in Patients With Good Physical, Mental Health: SYNTAXES

Higher Single-Sample hs-cTnT Threshold Can Safely Exclude MI

Good News and Bad for High-Intensity Statin Use in ASCVD

PCI and CABG Are Complementary Options for Left Main CAD, Say Experts

No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3

DISCHARGE Hailed as a Big Step Forward for CTA in Stable Chest Pain

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

British Medical Groups Express Concern About Inclisiran Rollout

Bentracimab Rapidly, Safely Reverses Ticagrelor in Early REVERSE-IT Data

No Mortality Difference Between PCI and CABG for Left Main CAD: Meta-analysis

Debating ISCHEMIA: Do the Results Apply to CABG, Too?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content